A double-blind, randomised, crossover comparison of granisetron and ondansetron in 5-day fractionated chemotherapy: Assessment of efficacy, safety and patient preference

This publication has 16 references indexed in Scilit:

• 5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy—A randomised study
  European Journal Of Cancer, 1993
• The antiemetic efficacy and safety of granisetron compared with metoclopramide plus dexamethasone in patients receiving fractionated chemotherapy over 5 days
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1993
• Are granisetron and ondansetron equivalent in the clinic?
  European Journal Of Cancer, 1992
• Are all 5-HT3 receptor antagonists the same?
  European Journal Of Cancer, 1992
• A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy
  European Journal Of Cancer, 1992
• Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
  New England Journal of Medicine, 1987
• A Log-Linear Model for Binary Cross-Over Data
  Journal of the Royal Statistical Society Series C: Applied Statistics, 1987
• Extrapyramidal Reactions with High-Dose Metoclopramide
  New England Journal of Medicine, 1983
• The Comparison of Success Rates in Cross-Over Trials in the Presence of an Order Effect
  Journal of the Royal Statistical Society Series C: Applied Statistics, 1981
• Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer Chemotherapy
  New England Journal of Medicine, 1979